What Smart Money Loves About Lilly

Quick Read Eli Lilly (LLY) beat Q4 EPS estimates by 12%. Zepbound holds nearly 70% of new obesity prescriptions. Lilly CEO and 12 executives collectively purchased $104M in shares during February. Lilly expects FDA approval for its oral GLP-1 orforglipron in Q2 2026. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE. Eli Lilly (NYSE: LLY) stock has pulled back 2.9% year-to-date to around $1,044, and institutional investors have been accumulating shares dur ...